. Thats why they didnt change their recommendation when the Phase 3 trial was published in Lancet. But not 150K. What happens when your prescription drug becomes the center of covid misinformation. Hes also recently increased the number of Americans he claim have been killed by the vaccine from 25,0000, to 150,000, or even as many as 250,000 Americans. Since making a fortune as the founder of Infoseek, an early search engine that was the Google of its day, Kirsch has spent tens of millions of dollars fighting humanitys biggest threats. It was completed in August. Steve put in $1MM of his own money and . Hes spending his own money to do what he thinks is right. Online Status. Fluvoxamine was reportedly added to just 2 practice guidelines (Ontario and Johns Hopkins). This looks ominous, but it harmless. It doesnt get any better than this. After boosting unproven covid drugs and campaigning against vaccines, Steve Kirsch was abandoned by his team of scientific advisersand left out of a job. Another is to identify an asteroid that is going to hit the planet.. How can we get fluvoxamine? In-patient use. Kirsch: Yes, but you could easily watch that 60 Minutes story and believe that we need more data before people should start using fluvoxamine. Mar. The choice couldn't be more clear cut. Another CETF grant, though, yielded far more exciting results. They left their recommendation of fluvoxamine at NEUTRAL. We should not wait for the Phase 3 RCT. In other cases, stop cold turkey. The NIH never did a risk benefit analysis of this drug. And, according to three members of CETFs scientific advisory board, he put pressure on them to promote fluvoxamine for clinical use without conclusive data that it worked for covid. My publicly shared concerns regarding the safety of the COVID-19 vaccines may have had a negative impact on my company, M10. Weve known it works since August 24, 2020. Note that a total of 77 people got the drug, not 65. CETF funded David Boulware's trials on hydroxychloroquine and the Phase 2 and Phase 3 fluvoxamine trials, among many other research projects. As Kirsch has gone deeper into the anti-vaccine scene, many professional associates have increasingly distanced themselves from him. . this is NOT about the science. Medium revoked my account for life. The drug was FDA-approved more than 65 years ago. The evidence is solid. (The fund borrows its nonprofit status from the 501(c)(3) Rockefeller Philanthropy Advisors, which managed its money until it quit, according to the Daily Beast; neither organization is related to the Rockefeller Foundation, which supports Technology Review's reporting on covid.). How covid-19 conspiracy videos keep getting millions of views. I will . 95% confidence effect size is 75% or more. See the repository above. If you are experiencing any odd adverse reactions, youll need to consult with your doctor ASAP. All can merit a fluvoxamine prescription based on traditional diagnoses. There are reports of people who cant tolerate the drug, but they stop using it and nothing bad happened. In the second trial, it was shown to be 100% effective in long-haul COVID symptoms: None of the treated patients had any long-haul symptoms after 2 weeks compared to 60% of untreated patients having 1 or more of the 15 long-haul symptoms after two weeks, and 29% having 4 of more of the long haul symptoms after 2 weeks. Links to evidence about fluvoxamine including the public data repository. If you start later, doctors use higher dosages and compliance becomes a bigger problem. These huge businesses do often prioritize profits over human health: in 2009, Pfizer paid a $2.3 billion settlement over kickbacks and fraudulent marketing, including a $1.3 billion felony fine. But the whole process has gone too slowly for Kirsch. In that same IEEE Spectrum story about his then-new startup, Propel Software, he said he felt successful, but not famous. He wrote on his personal website that hed been advised that being associated with the drug would immediately trash my credibility.. He may not be a good scientist, but hes smart, says WVUs Feinberg. Steve Kirsch is baffled. Why the FDA should grant an EUA for fluvoxamine immediately, Links to evidence about fluvoxamine including the public data repository, Here's the first one: When the pandemic started, he created the COVID-19 Early Treatment Fund (CETF) to fund researchers working on repurposed drugs including fluvoxamine which reduces death from COVID by a factor of 12. Discover special offers, top stories, JAMA systematic review and meta analysis It doesnt get any better than this. It does not matter how many lives will be saved. If you wanna find someone to debate me for ten thousand dollars, or a thousand dollars, Im happy to do that, just for your benefit.. At the end of May this year, Siliciano emailed the other advisors to say that Kirsch had gone off the deep end and he was cutting ties. (Siliciano did not respond to requests for comment for this article.). saying that the per-protocol analysis was arbitrary and other excuses. He started 7 high tech companies, two with billion dollar market caps. The NIH did nothing despite the fact the that NIH, FDA, CDC, and academic institutions participated in the panel, this is NOT about the science. If you start later, doctors use higher dosages and compliance becomes a bigger problem. Steve Kirsch Nov 5, 2021 145 92 Here are the key things you should know about fluvoxamine for COVID: It works. Fluvoxamine has a 40 year safety track record. Early research suggests that fluvoxamine, an FDA approved medication for depression and obsessive compulsive disorder, can be an effective early treatment for COVID-19. The U of M's study focused on three common drugs: ivermectin, metformin, and fluvoxamine. The NIH Guidelines committee is being very slow to react (we have no idea if they are even considering the drug because nobody is allowed to know that because all their deliberations are kept secret). The anecdotal data of 100% success rates is further icing on the cake. So much for evidence-based medicine. This site requires JavaScript to run correctly. Ivermectin has been falsely promoted as a covid treatmentbut for those who use the drug legitimately, seeing it become a piece of anti-vaccine misinformation is disconcerting. The US government accused Janssen of improperly promoting the antipsychotic drug Risperdal to dementia patients despite the drug increasing deaths in the elderly. By the beginning of September, he was no longer the companys CEO, replaced by his co-founder, Marten Nelson. That was a lie. . Kirsch did a lot of things right when he set up CETF. Thats why they didnt change their recommendation when the Phase 3 trial was published in Lancet. Im sorry to sound so cynical. One Silicon Valley entrepreneur thought he could beat the odds. 33. He has been a medical philanthropist for more than 20 years. All the supporting observational studies were positive as well. Author Affiliations . Less than a week later, David Seftel read about the Lenze trial, and ignored the JAMA advice. The 50mg BID dose was quite effective, but it has to be started early (as soon as symptoms start). Fluvoxamine is the poster child of the COVID-19 Early Treatment Fund (CETF). The babys brain was split in half, and it was just covered with blood. That is when the phase 2 results were published. Perhaps Kirschs most effective tactic, though, is simply his willingness to outlast everyone else. . David Boulware, a researcher at the University of Minnesota, received $125,000 to test the drug against covid. Compulsive fiddling with your mask? Mouse Systems is not a household word, he told the journalist. Kirsch and his group received a fresh wave of attention off hopeful trials of the antidepressant fluvoxamine, which ultimately won him a spot on 60 Minutes in March. 9th International Congress on Psychopharmacology 5th International Symposium on Child and Adolescent Psychopharmacology In it, he claimed mRNA vaccines kill one in 5,000 recipients and dramatically increase the rate of miscarriages. Who knows, Morris replied. It is currently approved for treatment of depression and obsessive compulsive disorder (OCD). The results would, eventually, set Kirsch on a collision course with the scientific establishment. Over the next few years, millions of unvaccinated people are going to get covid; its vital to try to mitigate their suffering, as well as lessen pressure on the health care system. You cannot get any better than that. Steve Kirsch -Executive Director at COVID-19 Early Treatment Fund Ivermection study - One .2mg/kg dose a week for prevention "100% success rate whereas those doctors taking placebo had a 59%% infection rate not a typo 237 of 400 docs on placebo got infected vs. 800 docs on Ivermectin none got infected" Antivirals Both drugs have compelling data that is hard to explain if the drug doesn't work. The ICER independent review showed fluvoxamine is more effective than Molnupiravir: Read this article I wrote about using fluvoxamine correctly for COVID. The paramedics will think you are on drugs. Those days are gone. How I recommend people treat COVID and the fascinating backstory of how fluvoxamine was discovered. We should be making decisions now based on the evidence on the table today. Get your prescription in advance of getting COVID. Fluvoxamine (Luvox) is a Selective Serotonin Receptor Inhibitor (SSRI) that is clinically indicated for OCD in children, and can be used off label for depression. All the medical journals refused to publish the meeting notes (rejected by 6 journals). You see this with people who have a lot of money, who think that reflects their intelligence, Richman told me. Substitutions. He has a BS/MS in Electrical Engineering and Computer Science from MIT. I think so. Items included in the Television News search service. . If you take fluvoxamine, please avoid caffeine while on the drug. 90,000 Americans will die from COVID in just the next 3 weeks, a third of recovered patients from COVID will return to the hospital within 5 months and 1 in 8 die, Lenze fluvoxamine RCT that was published in JAMA. Download Citation | On Mar 1, 2023, Gne Seda Albayrak and others published A Cross-Sectional Study on the Personality Traits of Episodic and Chronic Migraine Patients | Find, read and cite all . But the best way to help people is through rigorous trials that show what drugs help which people, and at what doses and timesnot by basing entire protocols on incredibly limited evidence. There are at least eight mechanisms of action that we think contribute to the effectiveness of this drug. Medicine isnt about saving lives anymore. sorry about that. If you have trouble getting a prescription, perhaps you have OCD? This advice is now outdated. The only way to do that is to treat them as early as possible with a drug that prevents hospitalization and death. Hes probably the closest thing Kirsch has to a nemesis, regularly disputing his assertions in blog posts and private email exchanges with Kirsch and his friends. Ive talked to doctors who are extremely familiar with the drug and all the trial results and they would prescribe it to their patients. $1M reward: Do we need more data re: Fluvoxamine for COVID-19? The reason is pure corruption. I have all of these on hand and I load up on vitamin D3 every day. I couldnt tell I was on the drug. Vaccine waitlist Dr. B collected data from millions. In some cases, youd want to taper down the dosage. It was tested in coronavirus patients because fluvoxamine has very strong anti-inflammatory properties. Server IP cope with resolved: Yes Http reaction code: 200 Response time: 0.27 sec. They all promised me when fluvoxamine passed Phase 3 trials, nearly everyone would use it. This suggests that a 50mg BID loading dose for day one, followed by 50mg QD dose for the following 13 days should also be quite effective. Food/drugs to avoid while on fluvoxamine. I couldn't agree more. (Clayton Fox, Marty Makary, and Jeffrey Klausner). Dr. Eric Lenze: So the results were really pretty. It is an amazing drug and is a very simple safe way to avoid long-haul COVID symptoms. Note that some of these articles are inaccurate. Patients should be advised to limit/avoid the use of caffeine while on the drug since fluvoxamine extends the half life of caffeine (making you super wired). Elsewhere he has said he began questioning vaccine safety after an unnamed Twitter follower told him several family members died after getting their shots. That covers almost 150,000 of them, which happened before vaccinations began. The group who declined the drug were very sick with 12.5% requiring hospitalization and one died. It works best when it is given early, as soon as symptoms start. Fluvoxamine is way better than Molnupiravir, but the NIH doesnt approve drugs on effectiveness. In a recent post, discussing claims Kirsch made during a three-minute comment at an FDA public forum, Morris wrote: In spite of many pages of writing and claims of over a dozen independent analyses verifying their results, their evidence falls far short of substantiating these dramatic conclusions, including a claim that vaccines have caused >250K excess deaths in the USA.. Long haul. The NIH picks the drug that makes the most money for the drug companies regardless of long-term safety Molnupiravir! All this was known back in January 2021 when a key opinion leader panel of experts from NIH, CDC, FDA, academia, and journal editors voted by over 2:1 to recommend that fluvoxamine be recommended to physicians to discuss with patients. The medical community doesnt care about saving lives. The findings, published Wednesday in the New England Journal of Medicine, add to a growing body of scientific evidence pushing back against the use of the antiparasitic drug that has been promoted by some prominent voices on social media. And, according to three members of CETF's scientific advisory board, he put pressure on them to promote fluvoxamine for clinical use without conclusive data that it worked for . Fluvoxamine at 50mg twice a day for 14 days is a very well-tolerated drug (as long as you avoid caffeine and alcohol) for the treatment of COVID infections. My crime? It is about following orders and making money for the drug companies and protecting the doctor from liability and losing his medical license. He might be a good snake oil salesman., I experienced this myself when, on one call, we discussed several studies. Completely avoid caffeine, alcohol, tylenol, and benadryl. He felt like he in good conscience had to speak out about covid, and so he made the decision to separate himself from M10, says Char, who has known Kirsch since the 1980s. . Fluoxetine is just as effective. Get your prescription in advance of getting COVID. The trials that were abandoned for futility werent getting events because the patients were given standard of care meds. Today, if we follow the CDC advice, nearly 100,000 people a month will die from COVID. Its sad, but its true, he told me. He's founded 7 companies, 2 with billion dollar valuations. People are dying because of physician fear of a new treatment with a 100% success rate and a solid mechanism of action. We asked Steve to tone it down. . Kirsch is a serial entrepreneur who has spent decades pitching the next big thing, whether optical mice (Mouse Systems), document processing (FrameMaker), search engines (Infoseek), digital. The NIH never did a risk benefit analysis of this drug. Fluvoxamine - The backstory T he i nsi de st ory behi nd how f l uvoxami ne became a CO V I D t herapy By Steve Kirsch Last updated: June 3, 2021 . Molnupiravir followed patients for only 30 days because they know the drug is dangerous. In the studies and the anecdotes I am aware of, everyone reversed symptoms within days of getting the drug. Its whether Merck can make a killing that matters. Months later, the site wont disclose how many doses it helped deliveror what it plans to do with user data. One is to reduce the threat of nuclear war. And while Morris believes that all claims about vaccine safety should be properly vettedIs it possible theres another rare side effect of the vaccines that we havent figured out yet? After several failed attempts to stop the progression of his disease, he designed his own protocol for chemotherapy and doctor-shopped to find an oncologist who would give it to him. Steve Kirsch is a high-tech serial entrepreneur based in Silicon Valley. Steve and CETF funded the research that showed promising results of fluvoxamine as an early treatment of COVID-19. The premise made sense: Most experts were predicting vaccines would take years, while finding helpful drugs with known safety profiles could shortcut the approval process. Both of them encouraged anyone reading this article to get vaccinated. His latest startup, M10, is a spin-off of a spin-off that sells a blockchain for banks. Still, in the moment, his question threw me, and I stuttered. He prefers iconoclastic approaches, whether by directly funding asteroid detection or advocating for nuclear power to combat global warming. 533. No one has been able to come up with an example where phase 2 + this level of evidence resulted in a failure of Phase 3. The NIH wrote a bullshit rejection because the FDA told them not to approve it. Independent appraisal committee votes 11-2 that the evidence is not adequate to demonstrate a net health benefit for molnupiravir over symptomatic care alone; Paxlovid and fluvoxamine receive more favorable votes. Those days are gone. NIH is still unsure whether fluvoxamine should be used to treat COVID. The CDC has advised everyone to wear a mask. The drug was widely prescribed as a covid treatment for much of 2020, based on anecdotes and flawed studies. I fully expected both organizations to do absolutely nothing. Fluvoxamine, COVID, pandemic, . Its all about NIH saying it is OK. . Pretty much nothing changed when the Phase 3 trial confirmed fluvoxamine worked. @stkirsch. Online. Hes very convincing. ICER, a non-profit known as the nations drug pricing watchdog, did a review of the evidence and determined that fluvoxamine evidence is superior to Molnupiravir. Last Checked: 03/03/2023. Steve Kirsch is an inventor of the optimal mouse, a Silicon Valley millionaire, and an MIT alum (Class of '80). They never make things worse so are safe to try. An approach that promised to democratize design may have done the opposite. After I ended the Zoom meeting, Satterfield called me to apologize for cutting us off. We pretty much practice government agency opinion medicine all over the world now, with just a few exceptions. Hes also publicly railed against what he claims is a campaign against drugs like fluvoxamine and ivermectin. On his blog, Covid-19 Data Science, he has extensivelyand mercilesslyunpacked Kirschs evidence for the vaccine death claims. He started a covid-19 vaccine company. So you can address your OCD and if you get COVID, youll can up the dose. Twenty-four years ago, . Every earlier study of fluvoxamine (such as observational studies) showed it work and the mechanism had been shown. Steve Kirsch: Vaccine Killing Millions, Treatments, VAERS, 5-Month Death Signal, Mystery Clots Embed 1.15K 'This Has Cost Millions of Lives': Steve Kirsch on Suppression of Repurposed Drugs and a Spike in Deaths 5 Months After Vaccine Rollout American Thought Leaders AMERICAN THOUGHT LEADERS JAN JEKIELEK Show more Loading comments. MisinformationKills. Design thinking was supposed to fix the world. I also think it makes a lot of sense to look for pre-existing drugs that can help treat covid symptoms. But Kirsch is also motivated by an unsatisfied competitive streak. Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI), a class of anti-depressants, mostly prescribed for people suffering from an obsessive-compulsive disorder. . He was recently featured on 60 Minutes, . He is very smart, and knows that he is very smart, and sometimes he behaves like he thinks he's the smartest guy in the room, whether he is or isn't., Kirschs response was to take his name off articles hed written about vaccine deaths, changing the authorship to VaccineTruth., On July 1, he tweeted from his personal account, My publicly shared concerns regarding the safety of the COVID-19 vaccines may have had a negative impact on my company, M10. Fluvoxamine, created 37 years ago, is an inexpensive and widely available generic drug. Three of the four outpatient trials have been reported out: all were successful. If you do have a side-effect, it is usually mild nausea which goes away when you stop taking the drug. Although the average effect size is 100% with a p-value of <.0001, The Fisher exact test on the combined data suggests that there is a 95% chance that the effect size is at least a 75% reduction in hospitalization rate. [https://www.quora.com/What-is-the-current-treatment-for-Covid-19/answer/, The most urgent need in the country right now is to reduce. Im not going to make the same mistake again.. Think about it Molnupiravir has a 50% risk reduction whereas fluvxoamine is over 90%. In other cases, stop cold turkey. . It was tested in. Fluvoxamine for COVID-19 summary Steve Kirsch Executive Director COVID-19 Early Treatment Fund stk@treatearly.org 650-279-1008 Google Docs This is a more comprehensive look at the key evidence supporting fluvoxamine: Fluvoxamine for COVID-19 Some countries dont have fluvoxamine so this is the alternative. But they dont want their names used. As a health care journalist, I started off firmly in the wait-and-see camp on mRNA vaccines. NIH doesnt want you to get the drug since it would compete with Molnupiravir, so fluvoxamine will never make the NIH guidelines. 4000fluvoxamine750 Pretty much nothing changed when the Phase 3 trial confirmed fluvoxamine worked. If you do have a side-effect, it is usually mild nausea which goes away when you stop taking the drug. Its whether Merck can make a killing that matters. My favorite dosage is 50mg twice a day for 14 days. So probability of successful Phase 3 can be estimated to be over 99.99% since there are tens of thousands of phase 3 studies. He has a history of giving away some of his millions to good causes, and when COVID-19 began. There are reports of people who cant tolerate the drug, but they stop using it and nothing bad happened. Steve is a Silicon Valley entrepreneur and philanthropist who founded the COVID-19 Early Treatment Fund (CETF) at the beginning of the pandemic. Eventually, a press representative who was listening in, David Satterfield, unmuted his microphone to suggest we finish our conversation by email. We look for advances that will have a big impact on our lives and break down why they matter. In some cases, youd want to taper down the dosage. The sooner you start, the better the outcomes. Hes also made several videos and podcasts with Vladimir Zelenko, the conspiracy theorist doctor who convinced Trump to take hydroxychloroquine. Its the gold standard of medical evidence. It has enrolled only 130 people in the first month and is enrolling only 70 per week now. It is very important to educate doctors because most people rely on their doctors for advice. One of the drugs, Fluvoxamine, showed a 30 . To vet proposals, he recruited a powerhouse advisory board of prominent biologists, drug developers, and clinical researchers, led by world-renowned drug researcher Robert Siliciano of Johns Hopkins. This looks ominous, but it harmless. At the dosing for COVID (50mg BID x 14 days), there is a 1% chance of mild-nausea and because the dose is so low and the time it is taken is so short, and there are no psychotropic effects (which require more than 3 weeks of use; the psychotropic effects non-existent if you don't have depression or an anxiety disorder in the first place). Kirsch, despite having direct access to the actual trial runner, eventually became convinced a correct interpretation of the data would show that hydroxychloroquine worked. Added to FLCCC protocols and Fareed-Tyson protocol among others. Online Status. Kirsch and his wife, Michele, fund a charitable foundation, which by 2007 had given $75 million to different causes. Also, for people who cant tolerate fluvoxamine for whatever reason (nausea, jittery, etc), this is the alternative. Jan 17. Kirsch, though, often relies on the heartstrings to smooth over a lack of data. Im just telling you the truth. Mr. Steve Kirsch - A philanthropist and former Silicon Valley tech executive. They all promised me when fluvoxamine passed Phase 3 trials, nearly everyone would use it. All this was known back in January 2021 when a key opinion leader panel of experts from NIH, CDC, FDA, academia, and journal editors voted by over 2:1 to recommend that fluvoxamine be recommended to physicians to discuss with patients. BOMBSHELL: Top biostats professor admits we have NO CLUE # of people KILLED by COVID vaccines, he wrote. 1. Read More fluvoxamine The Fluvoxamine FAQ MD, MPH; Steven C. Marcus, PhD. 707. It is an amazing drug and is a very simple safe way to avoid long-haul COVID symptoms. There are two ways Ive discovered that I may be able to save the world, he told an IEEE Spectrum reporter in 2000. He started a new pseudonymous account, @VaccineTruth2, to continue broadcasting messages. Most doctors wont use it until NIH greenlights it, no matter what the science says. CETF was founded by entrepreneur and philanthropist Steve Kirsch, as a way to expedite the fight against COVID-19. Fluvoxamine public data repository - Google Drive, On Cytokines, Fluvoxamine and COVID-19 Part 1, Jon-Emile S. Kenny MD[@heart_lung] You see, we have a kind of allergy to the past; its our national disease, and the very assurance with which you insist that the past is within the present is l, On Cytokines, Fluvoxamine and COVID-19 Part 2, Jon-Emile S. Kenny MD[@heart_lung] Apocalypse is played out now on a personal scale; it is not in the sky above us, but in our bed. -Mark Doty Introduction With a proposed pathway coupling patho, Effect of Fluvoxamine vs Placebo on Clinical Deterioration in Outpatients With Symptomatic COVID-19, This randomized trial compares the effects of fluvoxamine, a selective serotonin reuptake inhibitor with immunomodulatory effects vs placebo on a composite of dyspnea or pneumonia and oxygen desaturation among adult outpatients with polymerase chain reactionconfirmed mild coronavirus disease 2019 (, Prospective cohort of fluvoxamine for early treatment of COVID-19, Abstract. Dosing. There is absolutely no evidence that either one of these claims is true, as Morris has carefully documented. That study was featured on 60 Minutes. just like ivermectin). In 2013, Johnson & Johnson paid $2.2 billion for its own kickback and fraud scandal, including a specific $400 million fine for its subsidiary Janssen, which manufactures the covid vaccine. Boulware disputes that, and says that although Kirschs funding was important, his statements about drugs and vaccines have proven problematic. This was shown to be very tolerable (no side effects in 99% of patients) and extremely effective (no hospitalizations and death if you start it ASAP after first symptoms). Entrepreneur Steve Kirsch who holds an early patent for the optical mouse decided to get involved in treating Covid. While combining the results of several well-designed trials can strengthen an argument or unearth patterns unseen in smaller samples, a meta-analysis is just the sum of its parts; any single well-done experiment is more useful than combining the results of several poorly done ones. The External Medicine Podcast - Fluvoxamine as a potential treatment for COVID-19: An Interview with Steve Kirsch. Here are my answers. ALWAYS check with your doctor and report any medications you are taking before or plan to take after you start taking fluvoxamine. I couldnt tell I was on the drug. As of November 13, fluvoxamine has been proven to work in every trial that has published results, including outpatient and inpatient studies. Be warned!. This was shown to be very tolerable (no side effects in 99% of patients) and extremely effective (no hospitalizations and death if you start it ASAP after first symptoms). It is not unusual to be wary of developing science, or wrong to be skeptical of pharmaceutical companies. After two weeks (since it was a tight knit community, everyone could see what was happening to the two groups), every track worker who got sick with COVID, demanded the drug. Medicine today isnt about saving your life. We pretty much practice government agency opinion medicine all over the world now, with just a few exceptions. just like ivermectin). reach out to us at CETF funded David Boulware's trials on hydroxychloroquine and the Phase 2 and Phase 3 fluvoxamine trials, among many other research projects. People are dying. A very short op-ed arguing for using fluvoxamine against COVID. Several former members told me he began relentlessly pressuring them to promote the drug in media stories, often during exhausting, circuitous conversations. Compulsive hand washing? But as Kirsch has clashed with the experts he initially surrounded himself with, hes grown increasingly close to others who share his perspectives on vaccineswho have, in turn, provided a large and receptive audience to his claims about a fluvoxamine conspiracy.
Oak Ridge Police Department Detectives, Averitt Express General Counsel, Lambert Funeral Home Obituaries, Whale Ear Bones, Articles S